Inactivated Polio And Rabies Vaccines Market To Find Better Growth with US$ 1,418.2 Mn By 2027 | CAGR: 4.9%: Coherent Market Insights
Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Inactivated Polio and Rabies Vaccines Market, by Vaccine (Inactivated Polio Vaccine and Inactivated Rabies Vaccine), by Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), by Age Group (Pediatrics and Adults), By Distribution Channel (Government, and Private), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 966.6 Mn in 2019 and is expected to surpass US$ 1,418.2 Mn by 2027, exhibiting a CAGR of 4.9% over the forecast period (2019-2027) as highlighted in a new report published by Coherent Market Insights.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3581
Major market players are focusing on adopting inorganic strategies such as collaborations mergers, and acquisitions to expand their product portfolio and to strengthen their position in the global market, which is further expected to propel the global inactivated polio and rabies vaccines market growth over the forecast period. For instance, GlaxoSmithKline subunit, Chiron Behring was acquired by Bharat Biotech, in February 2019. Post-acquisition, in November 2019, Chiron Behring reintroduced anti-rabies vaccine, ChiroRab in India, in order to overcome the vaccination shortage in the country.
Moreover, key players are focusing on launching of new software, in order to record the dosage of the rabies vaccination as the patient is immunized with three dosage over the interval of few days. For instance, Kedrion Biopharma, launched a software, KEDRAB Dose calculator, in the U.S., in 2019, in order to help the healthcare providers to quickly and accurately determine the amount of KEDRAB to administer to rabies patients.
Several organizations, globally are providing monetary support to the manufacturers for the research and development of new vaccines against polio and rabies, with high efficacy and cost effective. For instance, in 2016, Batavia Biosciences, received US$ 13.2 million grant from the Bill and Melinda Gates Foundation to manufacture clinical-grade inactivated polio vaccine (sIPV) using its low cost polio vaccine manufacturing process, NevoLine manufacturing technology, which was developed by Univercells. The vaccine will cost around less than US$ 0.30 per dose, which was lower than the available vaccine by five times.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a free sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3581
In addition, many developed countries are focusing on initiatives for eradicating the life-threatening diseases by donating to organizations. For instance, the U.S. is the second largest donor to Global Polio Eradication Initiative, where the U.S. funded around US$ 235 million to the organization in the year 2019. The purpose of the Global Polio Eradication Initiative is to switch the oral polio vaccine (OPV) with the inactivated Polio Vaccine (IPV), as OPV consist of live, weakened poliovirus while the IPV consist of inactivated poliovirus. This initiative is expected to drive the global inactivated polio and rabies vaccines market growth over the forecast period.
Furthermore several economies are initiating initiatives for eradication of rabies from their countries. For instance, Ghana Health Service initiated a polio vaccination drive to immunize over two million, three hundred and sixty-two thousand four hundred and three children born between 2016 and February 2018, under the IPV campaign, in order to control the polio outbreak in Ghana. Furthermore, Ghana government launched a rabies prevention project in 2018, in which many dogs were immunized for rabies and the population was educated on the importance of rabies vaccination.
Browse 46 Market Data Tables, and 27 Figures spread through 179 Pages and in-depth TOC on Global Inactivated Polio and Rabies Vaccines Market, by Vaccine (Inactivated Polio Vaccine and Inactivated Rabies Vaccine), by Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), by Age Group (Pediatrics and Adults), by Distribution Channel (Government, Private), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2027.
To know the latest trends and insights prevalent in the Inactivated Polio and Rabies Vaccines Market Press Release, click the link below: https://bit.ly/2RSXcpI
Moreover, several non-government organizations, across the globe are focusing on creating awareness as well as offers low cost immunization to the population, which are expected to augment the global inactivated polio and rabies vaccines market growth over the forecast period. For instance, many low income countries population, who cannot afford the total cost of vaccination are supported by an external source for providing vaccination to the population. For instance, Gavi, the vaccine alliance, is an organization that running since a decade and its mission is to protect the world population from life-threatening epidemics by providing them proper immunization. They achieve their mission with the help of some partners such as World Health Organization (WHO), the United Nations Children’s Funds (UNICEF), The Bill and Melinda Gates foundation, vaccine manufacturers, research agencies, and others. In case of Poliomyelitis, Gavi organization supports 71 low income countries by providing them IPV at low cost. These countries receive cost effective treatment under Gavi Organization. For instance, in the U.S., the total cost of complete immunization of a child and adult comes around US$ 1,100, while the countries under Gavi receive the same set of vaccine for US$ 28. Thus such non-government organizations support the manufacturers by increasing the customer base globally aids in driving the global inactivated polio and rabies vaccines market growth.
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/3581
Key takeaways of the global inactivated polio and rabies vaccines market:
- The global inactivated polio and rabies vaccines market is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027), attributed to the increasing awareness among the population, globally. For instance, according to the WHO, 2019, increasing awareness among the population and increasing polio drives globally has led to the eradication of type 2 strain of poliovirus in the year 2019. Type 2 strain of poliovirus was eradicated in the year 2015. Only type 1 strain of poliovirus still remains among the population.
- Major market players are also focusing on manufacturing of low-cost IPV. For instance, Nevoline is the Univercells SA automated bioproduction system for the manufacture of IPV, which was installed at Batavia Biosciences Polio dedicated facility in Leiden, Netherlands. Nevoline manufactures product in a faster, smaller, and closed bioprocessing unit, and is environmentally safe. The cost of the IPV manufactured from Nevoline would reduce 5 fold as compared to the currently used process to manufacture IPVs.
- Key players operating in the global inactivated polio and rabies vaccines market include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc. Bilthoven Biologicals, Merck & Co., Inc., and Pfizer Inc, among others.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3581
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire